PSA vs TECH
PSA (PSA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PSA currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PSA and TECH stock pages for the full models.
Not investment advice.